INMUNE BIO INC's ticker is and the CUSIP is 45782T955. A total of 1 filers reported holding INMUNE BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | +1075.0% | 7,000 | +1300.0% | 0.00% | – |
| Q2 2023 | $4 | -50.0% | 500 | -64.3% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 1,400 | -75.4% | 0.00% | – |
| Q3 2022 | $35,000 | +133.3% | 5,700 | +235.3% | 0.00% | – |
| Q2 2022 | $15,000 | -88.5% | 1,700 | -89.1% | 0.00% | – |
| Q1 2022 | $131,000 | +718.8% | 15,600 | +875.0% | 0.00% | – |
| Q4 2021 | $16,000 | -73.3% | 1,600 | -51.5% | 0.00% | – |
| Q3 2021 | $60,000 | +5.3% | 3,300 | 0.0% | 0.00% | – |
| Q2 2021 | $57,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |